Clinical and treatment characters | RP | Non-RP | P |
---|---|---|---|
Age (years) | 67 (33–84) | 65 (47–85) | 0.141 |
Sex | 0.367 | ||
Male | 27 | 75 | |
Female | 13 | 23 | |
Tumor location | 0.165 | ||
Left | 16 | 53 | |
Right | 24 | 47 | |
ITV Volume (cc) | 9.84 ± 9.00 | 10.89 ± 12.02 | 0.411 |
Dose fractionations | 0.626 | ||
60 Gy/8 fractions | 12 | 31 | |
50 Gy/4 fractions | 6 | 18 | |
50 Gy/5fractions | 21 | 48 | |
Others | 1 | 3 | |
Volume dose | |||
V5 | 18.02 ± 7.54 | 15.27 ± 6.64 | 0.221 |
V10 | 11.08 ± 4.70 | 8.74 ± 3.95 | 0.250 |
V20 | 5.49 ± 2.85 | 4.34 ± 2.53 | 0.547 |
MLD (Gy) | 3.39 ± 1.54 | 3.28 ± 1.41 | 0.394 |